title: Direct-Conversion Molecular Breast Imaging of Invasive Breast Cancer: Imaging Features, Extent of Invasive Disease, and Comparison Between Invasive Ductal and Lobular Histology.
abstract: OBJECTIVE
  The purposes of this study were to compare the tumor appearance of invasive breast cancer on direct-conversion molecular breast imaging using a standardized lexicon and to determine how often direct-conversion molecular breast imaging identifies all known invasive tumor foci in the breast, and whether this differs for invasive ductal versus lobular histologic profiles.
  
  
  METHODS
  Patients with prior invasive breast cancer and concurrent direct-conversion molecular breast imaging examinations were retrospectively reviewed. Blinded review of direct-conversion molecular breast imaging examinations was performed by one of two radiologists, according to a validated lexicon. Direct-conversion molecular breast imaging findings were matched with lesions described on the pathology report to exclude benign reasons for direct-conversion molecular breast imaging findings and to document direct-conversion molecular breast imaging-occult tumor foci. Associations between direct-conversion molecular breast imaging findings and tumor histologic profiles were examined using chi-square tests.
  
  
  RESULTS
  In 286 patients, 390 invasive tumor foci were present in 294 breasts. A corresponding direct-conversion molecular breast imaging finding was present for 341 of 390 (87%) tumor foci described on the pathology report. Invasive ductal carcinoma (IDC) tumor foci were more likely to be a mass (40% IDC vs 15% invasive lobular carcinoma [ILC]; p < 0.001) and to have marked intensity than were ILC foci (63% IDC vs 32% ILC; p < 0.001). Direct-conversion molecular breast imaging correctly revealed all pathology-proven foci of invasive disease in 79.8% of cases and was more likely to do so for IDC than for ILC (86.1% vs 56.7%; p < 0.0001). Overall, direct-conversion molecular breast imaging showed all known invasive foci in 249 of 286 (87%) patients.
  
  
  CONCLUSIONS
  Direct-conversion molecular breast imaging features of invasive cancer, including lesion type and intensity, differ by histologic subtype. Direct-conversion molecular breast imaging is less likely to show all foci of ILC compared with IDC.
authors: 1 Department of Radiology, Breast Imaging, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
authors: Amy Lynn
authors: AL
authors: Conners
authors: 1 Department of Radiology, Breast Imaging, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
authors: Katie N
authors: KN
authors: Jones
authors: 2 Department of Radiology, Medical Physics, Mayo Clinic, Rochester, MN.
authors: Carrie B
authors: CB
authors: Hruska
authors: 3 Department of Biomedical Statistics, Mayo Clinic, Rochester, MN.
authors: Jennifer R
authors: JR
authors: Geske
authors: 4 Department of Surgery, Mayo Clinic, Rochester, MN.
authors: Judy C
authors: JC
authors: Boughey
authors: 5 Department of Internal Medicine, Mayo Clinic, Rochester, MN.
authors: Deborah J
authors: DJ
authors: Rhodes
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis*; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis*; D018275:Carcinoma, Lobular / Q000175:diagnosis*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008875:Middle Aged; D057054:Molecular Imaging; D019275:Radiopharmaceuticals; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi
chemical_list: D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi
keywords: breast cancer; invasive ductal carcinoma; invasive lobular carcinoma; molecular breast imaging